IL2 and COVID-19: Among CD4+ T cells, we identified clusters of cells characterized by higher simultaneous production of different combinations of IL-2, TNF-α, CD107a and IFN-γ, at the recovery time-point I in severe convalescent patients, compared to moderate and mild post-COVID19, as well as healthy individuals (Figure 6A).